NEW YORK (GenomeWeb News) – GenOway, a French firm that develops transgenic mice and rats, began trading on Euronext’s Alternext exchange on April 5, the company said this week.
 
The company raised €27.7 million ($37.4 million) in its initial public offering, trading 5.6 million shares at €4.96 per share.
 
The company’s shares are trading at €6 today.
 
The Alternext, which opened two years ago, is a Euronext market designed for small and mid-cap companies.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.